Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html).

Term:percentage of study population displaying experimental diabetes mellitus at a point in time
go back to main search page
Accession:CMO:0001993 term browser browse the term
Definition:The number of individuals in a study population which display experimental diabetes mellitus at a certain point in time compared to the total number of individuals in the study population, expressed as a percentage. Experimental DM is diabetes induced experimentally by administration of various diabetogenic agents or by removal of all or part of the pancreas.
Synonyms:related_synonym: experimental diabetes mellitus prevalence
 xref: MESH:D003921



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 210529
    disease population measurement 27
      disease incidence/prevalence measurement 27
        diabetes mellitus incidence/prevalence measurement 0
          percentage of study population displaying diabetes mellitus at a point in time 0
            percentage of study population displaying experimental diabetes mellitus at a point in time 0
paths to the root